tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GLUE Stock Latest News

Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day
Press ReleasesMonte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day
9d ago
GLUE
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
PremiumStock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
16d ago
GLUE
ZURA
Monte Rosa Therapeutics Reports Progress on Drug Development
PremiumCompany Announcements
Monte Rosa Therapeutics Reports Progress on Drug Development
20d ago
8K
GLUE
Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160
PremiumPress Releases
Monte Rosa Therapeutics Provides Development Progress Updates on MRT-2359 and MRT-6160
20d ago
GLUE
Monte Rosa provides development progress updates on MRT-2359, MRT-6160
PremiumThe Fly
Monte Rosa provides development progress updates on MRT-2359, MRT-6160
20d ago
GLUE
Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis
PremiumPress ReleasesMonte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis
1M ago
GLUE
Monte Rosa Therapeutics presents preclinical data on MRT-6160
PremiumThe Fly
Monte Rosa Therapeutics presents preclinical data on MRT-6160
1M ago
GLUE
Monte Rosa Therapeutics Appoints Jennifer Champoux as COO
PremiumCompany Announcements
Monte Rosa Therapeutics Appoints Jennifer Champoux as COO
2M ago
8K
GLUE
Monte Rosa Therapeutics announces leadership team promotions
PremiumThe Fly
Monte Rosa Therapeutics announces leadership team promotions
2M ago
GLUE
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease
PremiumPress Releases
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease
2M ago
GLUE
Monte Rosa Therapeutics presents data at DDW 2024 on MRT-6160
PremiumThe Fly
Monte Rosa Therapeutics presents data at DDW 2024 on MRT-6160
2M ago
GLUE
Monte Rosa Therapeutics 10.6M share Spot Secondary priced at $4.70
PremiumThe Fly
Monte Rosa Therapeutics 10.6M share Spot Secondary priced at $4.70
2M ago
GLUE
Monte Rosa prices 10.6M shares at $4.70 in underwritten public offering
PremiumThe FlyMonte Rosa prices 10.6M shares at $4.70 in underwritten public offering
2M ago
GLUE
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
PremiumPress Releases
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
2M ago
GLUE
Monte Rosa Therapeutics announces offering of common stock, warrants
PremiumThe Fly
Monte Rosa Therapeutics announces offering of common stock, warrants
2M ago
GLUE
Monte Rosa Therapeutics expects cash and cash equivalents sufficient into 1H26
PremiumThe Fly
Monte Rosa Therapeutics expects cash and cash equivalents sufficient into 1H26
2M ago
GLUE
Monte Rosa Therapeutics reports Q1 EPS (53c), consensus (57c)
PremiumThe Fly
Monte Rosa Therapeutics reports Q1 EPS (53c), consensus (57c)
2M ago
GLUE
Monte Rosa Therapeutics Corporate Presentation Release
PremiumCompany Announcements
Monte Rosa Therapeutics Corporate Presentation Release
2M ago
8K
GLUE
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
2M ago
GLUE
Monte Rosa Therapeutics Announces Key Management Changes
PremiumCompany AnnouncementsMonte Rosa Therapeutics Announces Key Management Changes
3M ago
8K
GLUE
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
PremiumPress Releases
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
3M ago
GLUE
Truist biotech analyst to hold an analyst/industry conference call
PremiumThe Fly
Truist biotech analyst to hold an analyst/industry conference call
3M ago
GLUE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >